CIK 0001404281 · Non-accelerated filer<br>Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- 8-K Event Other events
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- 8-K Event Bylaws or fiscal year change
- 4 Open-market buy 10% owner bought 150,000 shares at $15.00 ($2,250,000)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 237,500 shares at $15.00 ($3,562,500)
- 4 Conversion Director acquired 4,218,632 shares (conversion)
- 4 Open-market buy Director bought 362,500 shares at $15.00 ($5,437,500)
- 4 Open-market buy 10% owner bought 325,000 shares at $15.00 ($4,875,000)
- 4 Conversion Director acquired 121,077 shares (conversion)
- 4 Derivatives Options or other derivatives
- CT ORDER Other Confidential Order
- 4 Grant or award Chief Financial Officer acquired 54,604 shares (grant or award)
- 424B4 Offering Prospectus
- FWP Offering Free Writing Prospectus
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
Page 29 of 31 · 616 filings